This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Covid-19
Only some post COVID-19 condition symptoms specific to the virus
Read more
Vaccination found to reduce risk of post-COVID-19 condition
Read more
Higher level of advanced colorectal cancer diagnosed during COVID-19
Read more
Myocarditis rate higher in younger people following mRNA vaccination
Read more
Telmisartan fails to improve disease severity among patients hospitalised with COVID-19
Read more
Post-COVID-19 condition persists for at least 2 years
Read more
Review suggests serum vitamin D levels might protect against developing COVID-19
Read more
Review finds tixagevimab/cilgavimab effective for immunocompromised patients
Read more
Study finds COVID-19 vaccine confidence declined since pandemic
Read more
mRNA-1273 vaccine response non-inferior to young adults in children from 6 months
Read more
Omicron BA.2 sub-variant associated with less severe disease
Read more
Adverse cardiovascular outcomes higher in patients hospitalised with COVID-19
Read more
Antibody response from Omicron BA.4/BA.5 bivalent booster similar to original vaccine
Read more
Limited recovery benefits from remdesivir following COVID-19
Read more
Omicron BA.4/BA.5-adapted bivalent vaccine increases antibody response
Read more
Molnupiravir treatment improves recovery time in high-risk vaccinated patients
Read more
Haemodialysis patients with COVID-19 benefit from remdesivir
Read more
Page 2 of 27
«
1
2
3
4
5
...
10
20
...
»
Last »
Popular articles
Third of patients in favour of AI-supported consultations and clinical documents, study finds
18 April, 2024
Bimekizumab gains EC approval for hidradenitis suppurativa
22 April, 2024
Semaglutide shows promise in patients with type 2 diabetes and obesity-related heart failure
22 April, 2024
x
Search for: